The Food and Drug Administration (FDA) has granted SYM-1219 (secnidazole, Symbiomix) Fast Track designation for the treatment of bacterial vaginosis (BV).
Based on a new study published in Neurology, researchers have developed the first clinical recommendations for making diagnostic decisions regarding headaches in pregnant women.
The Food and Drug Administration (FDA) has approved Addyi (flibanserin) for the treatment of premenopausal women with acquired, generalized hypoactive sexual desire disorder (HSDD) as characterized by low sexual desire that causes marked distress or interpersonal difficulty and is not due to a co-existing medical or psychiatric condition, problems within the relationship, or the effects of a medication or other drug substance.
Significantly different microbiomes were seen in the reproductive tracts of pregnant women who had a baby born prematurely vs. women who delivered full term.
Cycle Technologies announced the launch of Dot, a period-tracking and fertility app to evaluate a woman's risk of pregnancy for each day of her cycle.
Women who conceive following in vitro fertilization (IVF) are significantly more likely to develop gastroesophageal reflux disease (GERD) at least one year after delivery, although the risk does not vary with singleton and twin births, according to a study in the United European Gastroenterology Journal.
A new study in the Journal of the American Academy of Orthopaedic Surgeons (JAAOS) suggests that imaging studies used to diagnose traumatic injuries sustained by pregnant women are safe when used properly.
Results from a cohort study evaluating over one million pregnant women enrolled in Medicaid revealed that nitrofurantoin was the most commonly dispensed medication during pregnancy.
Contrary to prior research, a study appearing in Obstetrics & Gynecology reports no increased risk of seizures in neonates born to mothers exposed to calcium channel blockers (CCBs) in late pregnancy.
An analysis has found that using oral contraceptives for even a few years can give long-term protection against endometrial cancer, showing greater risk reduction with longer use.
The use of selective serotonin reuptake inhibitors (SSRIs) to treat maternal psychiatric disorders was linked to a lower risk of preterm birth and a delivery but a higher risk of neonatal problems.
Postmenopausal women did not experience beneficial effects on bone mineral density, muscle function, muscle mass or falls with high-dose vitamin D, according to a study published in JAMA Internal Medicine.
Many new mothers do not receive advice from clinicians on infant care or receive advice from healthcare professionals or family members that is not consistent with recommendations and guidelines, reports a new study in Pediatrics.
Use of emergency contraception by female teenagers has increased over the past decade while the percentage of both male and female teenagers who have had sexual intercourse has decline since 1988, according to new data from the Centers for Disease Control and Prevention's (CDC) National Center for Health Statistics (NCHS).
An investigational drug to treat hot flashes and other menopausal symptoms selectively delivers estrogen only to the brain, sparing other organs from hormone exposure and potential side effects.
A baby's first stool may indicate that the child could have difficulty in cognitive development, new research from the Case Western Reserve University Project Newborn has shown.
Giving antidiabetic drugs to obese pregnant women may not prevent their babies from being born overweight, according to a study published in The Lancet Diabetes and Endocrinology.
A study in BMJ reports that an increased risk of birth defects was seen with use of some selective serotonin reuptake inhibitors (SSRIs) during early pregnancy, but that the absolute risk is still low if the association is indeed causal.
HPSRx announced the launch of Caya, a non-hormonal contoured diaphragm for use as a female contraceptive barrier device for up to two years.
A significant drop in out-of-pocket spending for oral contraceptives and intrauterine devices (IUDs) has been evident since the Affordable Care Act (ACA) went into effect, according to a study published in Health Affairs.
Bayer HealthCare announced that the Food and Drug Administration (FDA) has approved an alternate confirmation test for Essure inserts, administered three months following the procedure for hysteroscopic sterilization.
There appears to be a difference in contraception use among female adolescents based on weight, as new research appearing in the Journal of Pediatrics found that sexually active obese adolescents were significantly less likely to use contraception compared to their normal weight peers.
The Food and Drug Administration (FDA) has approved Tri-Lo-Estarylla (ethinyl estradiol, norgestimate; Sandoz) tablets for oral contraception.
Children who were born via cesarean section delivery were 21 percent more likely to be diagnosed with autism spectrum disorder (ASD) but this link was not found to be causal upon further analysis of sibling pairs, new research has found.
The PeriCoach System is now available to strength and tone pelvic muscles in women with urinary incontinence following its approval in March 2015.
A computer model predicts that offering women immediate postpartum etonogestrel implant insertion could be extremely cost-effective for both new mothers and medical insurance companies.
A drug indicated for the treatment of attention deficit hyperactivity disorder (ADHD) and binge eating disorder also helped women with executive functions related to menopause in research appearing in the journal Psychopharmacology.
A study presented at the European League Against Rheumatism Annual Congress (EULAR 2015) indicates that use of some non-steroidal anti-inflammatory drugs (NSAIDs) could have a negative impact on female fertility, even with short-term use.
Interest in potential health benefits with consuming the placenta postpartum has increased in recent years, but a review in the Archives of Women's Mental Health found inconclusive data on the perceived health benefits with placentophagy.
The Food and Drug Administration (FDA) Advisory Committee has voted 18-6 in favor of approving flibanserin, an investigational agent for the treatment of hypoactive sexual desire disorder (HSDD) in premenopausal women if certain risk management options beyond labeling are implemented.
While a new study appearing in the Journal of the American Medical Association suggests that use of antidepressants in late pregnancy may be associated with an increased risk of persistent pulmonary hypertension of the newborn (PPHN), the absolute risk is small and the risk increase appears to be less than previous studies have suggested.
Research published in Clinical Gastroenterology and Hepatology showed that nearly all pregnant women with hepatitis B virus (HBV) taking telbivudine had undetectable levels of HBV DNA in cord blood, with no severe adverse events or complications observed in women or infants.
Vitamin D and calcium supplements do not appear to reduce menopausal symptoms in older women, reports a new study published in Maturitas, the official journal of the European Menopause and Andropause Society.
Prolonged acetaminophen use (1 week) by pregnant women may suppress fetal testosterone production, according to researchers from the University of Edinburgh.
A new study in JAMA reports that a significant reduction in the rate of dispensing of codeine to postpartum women was observed following public health advisories from the U.S. Food and Drug Administration (FDA) and Health Canada on potentially life-threatening adverse effects in infants of breastfeeding mothers taking codeine.
A study by the Centers for Disease Control and Prevention (CDC) and Cedars-Sinai proposes that the 9-valent human papillomavirus (HPV) vaccine could prevent 80 percent of cervical cancers in the United States if administered to all 11- or 12-year-old children prior to exposure to the virus.
A simple electronic reminder during an office visit may encourage more patients to get the human papillomavirus (HPV) vaccine to protect against cervical cancer, researchers have found.
Medolac Laboratories and the Mothers Milk Cooperative announced the launch of Co-op Donor Milk, the first direct-to-consumer human donor milk that can be stored at room temperature.
Bayer HealthCare announced results from a study that support previous findings on the effectiveness and safety of the Essure inserts and procedure for hysteroscopic sterilization.
Abbott announced that the Food and Drug Administration (FDA) has granted clearance for the i-STAT Total β-hCG blood test to detect if a woman is in the early stages of pregnancy.
A high-dose treatment of sodium nitrite and citric acid creams applied twice daily was more effective than placebo for treating anogenital warts, according to a new study in JAMA Dermatology.
Cranberry extract may lower the risk of urinary tract infection (UTI) by 50% in women who have a catheter in place while undergoing elective gynecological surgery.
The Food and Drug Administration (FDA) has granted Orphan Drug designation to Cantrixil (TRXE-002; CanTx Inc.) for ovarian cancer.
In utero exposure to hyperemesis gravidarum (HG) is linked to a three-fold increase in risk of a neurodevelopmental diagnosis such as attention deficit hyperactivity disorder (ADHD), reports the first study to examine this relationship.
Researchers may have discovered a mechanistic explanation and preliminary evidence to support previous findings that mothers of twins are more likely to have smoked, despite smoking's potential deleterious effects on fertility.
In a study published in JAMA, intrauterine exposure to gestational diabetes by 26 weeks was linked to a risk of autism spectrum disorders (ASDs).
Researchers from Vanderbilt University Medical Center have found that most babies exposed to opioid pain relievers were more likely to be preterm, have complicated births, low birth weight, and have meconium aspiration syndrome and respiratory distress.
Actavis and Medicines360 announced the launch of Liletta (levonorgetsrel-releasing intrauterine system) 52mg for the prevention of pregnancy for up to 3 years.
Use of long-action reversible contraception (LARC), such as intrauterine devices (IUDs) and implants, increased from 2005-2013 among teens aged 15-19 seeking contraceptive services, according to the Centers for Disease Control and Prevention (CDC)'s Morbidity and Mortality Weekly Report (MMWR).
The FDA has granted Breakthrough Therapy designation to rucaparib (Clovis Oncology) as monotherapy treatment of advanced ovarian cancer in patients who have received at least two lines of prior platinum-containing therapy, with BRCA-mutated tumors, inclusive of both germline BRCA (gBRCA) and somatic BRCA (sBRCA) mutations.
Overconsumption of junk food late in pregnancy may be more harmful to the child than excess junk food early in the pregnancy, researchers from the University of Adelaide have shown.
A review published in The Obstetrician & Gynaecologist emphasizes that accurate blood pressure measurement is vital to the early diagnosis of hypertensive disorders in pregnancy.
AirStrip announced that the Food and Drug Administration (FDA) has cleared the AirStrip Sense4Baby wireless maternal/fetal monitoring system for use by pregnant patients to self-administer non-stress tests (NST).
Ultrasound is more cost-effective and safer than other imaging technologies for imaging the female pelvis and it should be the first modality used for patients with pelvic symptoms, advocates of the American Institute of Ultrasound in Medicine (AIUM) have proposed.
Glyburide use in mothers with gestational diabetes mellitus (GDM) was associated with an increased risk for newborns to be admitted to an intensive care unit, have respiratory distress, hypoglycemia, birth injury, and be large for gestational age compared to infants born to women treated with insulin.
Multiple studies have shown that walnuts may have a positive impact on important health conditions such as colon cancer, cognitive aging, and gut and vascular health.
The Endocrine Society has issued a response to the USPSTF's final recommendation statement on screening for thyroid dysfunction.
Results from a large birth cohort study suggest women may not be consuming enough omega-3 to meet the recommendations for pregnancy and lactation.
Auxogyn announced the availability of the Eeva Test to help the embryo selection process by taking images of the embryos during the incubation period.
Church & Dwight announced the expected launch of First Response Reproductive Health Multivitamin Gummies and PreNatal & PostNatal Multivitamin Gummies, an extension of the First Response product line.
Hormone therapy combined with statins may help protect women from heart disease or stroke after menopause, data from a Swedish population study has shown.
Afaxys announced the launch of EContra EZ (levonorgestrel) tablet, an over-the-counter (OTC) emergency contraceptive.
Hospira has announced a voluntary recall of one lot of Magnesium Sulfate in 5% Dextrose 10mg/mL Injection after confirmed customer reports of an incorrect barcode on the primary bag labeling.
In an updated position paper, the Academy of Nutrition and Dietetics stated that breastfeeding provides the best nutrition for infants and very young children.
Women whose children are at risk for developing asthma should avoid antibiotics to the extent that they can, a study published in the Annals of Allergy, Asthma and Immunology reports.
The Food and Drug Administration (FDA) has approved Liletta (levonorgestrol-releasing intrauterine system; Actavis and Medicines360) for use by women to prevent pregnancy for up to three years.
Pregnant women with various classes of obesity should not gain any weight until mid-pregnancy or later for optimal pregnancy outcomes, according to a new study in the journal Obesity.
Researchers at Albert Einstein College of Medicine of Yeshiva University have discovered a potential explanation as to why older mothers face a greater risk for having offspring born with conditions characterized by abnormal chromosome numbers, such as Down syndrome.
Women with no history of depression who deliver a stillbirth may have an increased risk for long-lasting depression, according to research.
Sprout Pharmaceuticals has resubmitted its New Drug Application (NDA) to the FDA for flibanserin for Hypoactive Sexual Desire Disorder (HSDD) in premenopausal women.
The Food and Drug Administration (FDA) has granted marketing of Pelvalon's Eclipse System for the treatment of fecal incontinence in females aged 18-75 years old who have had more than four episodes in a two-week period.
Noven announced the launch of Minivelle (estradiol transdermal system) 0.025mg/day, a new low dosage strength approved for the prevention of postmenopausal osteoporosis.
Hormonal intrauterine devices (IUDs) and contraceptive implants remain effective one year beyond their approved duration of use, preliminary research has shown.
The Food and Drug Administration (FDA) has granted accelerated approval to Ibrance (palbociclib; Pfizer) capsules for the treatment of postmenopausal women with estrogen receptor (ER)-positive, human epidermal growth factor receptor 2 (HER2)-negative advanced breast cancer as initial endocrine-based therapy for their metastatic disease, in combination with letrozole.
Bioceptive announced it has received clearance from the Food and Drug Administration (FDA) for its suction cervical retractor for use in various gynecological procedures.
A new study shows the need for more interventions to reduce opioid prescriptions among women of reproductive potential, especially when safer alternatives are available or when opioid use is unnecessary.
An undergraduate student at Cornell University has designed a collection of maternity wear that can also wirelessly monitor the mother's health using conductive silver fibers in the clothing fabric.
New research by the Centers for Disease Control and Prevention (CDC) supports the protective effect of folic acid supplementation against recurrent neural tube defects (NTD).
Afaxys announced the availability of Tarina Fe 1/20 (norethindrone acetate and ethinyl estradiol tablets and ferrous fumarate tablets, 1mg/20mcg/75mg) for the prevention of pregnancy in women who choose to use oral contraceptives as a method of contraception.
The Food and Drug Administration (FDA) has issued a statement regarding the benefits and potential risks associated with the use of prescription and over-the-counter (OTC) pain medications during pregnancy in response to recent reports questioning their safety when used during pregnancy.
AbbVie announced positive results from one of two ongoing Phase 3 trials for elagolix in premenopausal women with endometriosis.
A new study shows that women who experience menopausal symptoms (eg, severe hot flashes, night sweats) tend to have lower bone mineral density and higher rates of hip fractures vs. women who do not have menopausal symptoms.
The Food and Drug Administration (FDA) has granted accelerated approval for Lynparza (olaparib; AstraZeneca) for the treatment of advanced ovarian cancer associated with defective BRCA genes.
The Food and Drug Administration (FDA) is warning consumers that fetal ultrasound imaging and Doppler fetal ultrasound heartbeat monitors are prescription devices designed to be used by trained healthcare professionals and are not intended for over-the-counter (OTC) sale or use for creating fetal keepsake images and videos.
The Centers for Disease Control and Prevention (CDC) has released its annual fact sheet of the three reported sexually transmitted diseases (STDs): chlamydia, gonorrhea, and syphilis.
The Food and Drug Administration (FDA) has granted the first-ever waiver under specific laboratory regulation for Syphilis Health Check test to be used in expanded healthcare settings.
The Food and Drug Administration (FDA) has approved Gardasil 9 (9-valent human papillomavirus types, recombinant; Merck) vaccine for the prevention of cervical, vulvar, vaginal, anal cancers, and for the prevention of genital warts caused by nine types of human papillomavirus (HPV).
BioPharmX announced the launch of Violet iodine, a first-of-its-kind pill for relief of premenstrual breast discomfort.
The birth rate declined in the United States for the sixth straight year in 2013, with the general fertility rate at an all-time low.
The Food and Drug Administration (FDA) has issued a final rule to standardize how information is presented in labeling of prescription drugs and biologics regarding the use of medicines during pregnancy and breastfeeding.
The Food and Drug Administration (FDA) is warning against the use of laparoscopic power morcellators in hysterectomy or myomectomy procedures for the majority of women.
According to research presented at the American Heart Association's Scientific Sessions 2014, adults whose mothers were overweight or obese pre-pregnancy may have a significantly increased risk of dying from heart disease or stroke.
Taking a three-drug regimen during pregnancy prevented mother-to-child HIV transmission more effectively than taking one drug during pregnancy, another during labor, and then two more after giving birth, according to results of an ongoing international clinical trial.
Certain chemicals used in sunscreens and other personal care products have been linked to reduced fecundity in men, according to a study appearing in the American Journal of Epidemiology.
Genentech announced that the Food and Drug Administration (FDA) has approved Avastin (bevacizumab) in combination with chemotherapy for the treatment of women with platinum-resistant, recurrent ovarian cancer.
Afaxys announced the wider availability of ella (ulipristal acetate), an emergency contraceptive, after acquiring U.S. marketing rights.
Mission Pharmacal announced the launch of CitraNatal basic, an over-the-counter (OTC) prenatal vitamin for pre-pregnancy nutritional support.
A standard prenatal treatment in the United States and other high-income countries for pregnant women at high risk for preterm birth may potentially cause harm if implemented in low-income countries, according to new findings.
The Food and Drug Administration (FDA) has accepted for filing and granted Priority Review to the NDA for palbociclib in combination with letrozole, as a first-line treatment of postmenopausal women with ER+, HER- advanced breast cancer who have not received previous systemic treatment for their advanced disease.
Strong evidence from a new study in human placenta suggests that Endocrine Disrupting Chemicals (EDCs) can interfere with the action of thyroid hormones in pregnant women.
- Nine Factors That Appear to Elevate Alzheimer's Risk
- NSAIDs Linked to Long-Term Colon Cancer Risk Reduction
- Clinical Suspicion Leads to Uncommon Diagnosis in Patient With High Fever
- What a New Study Says About Omega-3s and Brain Health
- Measles and 'Immune Amnesia': Why Vaccination Could Also Prevent Other Diseases